Translational Session
Dietary and Metabolic Interventions in ADPKD: The Rationale and Clinical Benefit
November 03, 2023 | 04:30 PM - 06:00 PM
Location: Room 114 (Nutter Theatre), Pennsylvania Convention Center
Session Description
ADPKD cells exhibit metabolic abnormalities including increased aerobic glycolysis (Warburg effect). Recent pilot studies, along with preclinical experiments, demonstrate that dietary interventions and interventions to address metabolic abnormalities may be able to slow ADPKD progression. This session provides an overview on metabolic abnormalities seen in ADPKD and the biological justification for targeting these changes to modify disease. Talks include discussion of recent mechanistic and clinical trial data that support these new approaches.
Learning Objective(s)
- Explain how abnormal cellular biology of ADPKD epithelium results in enhanced aerobic glycolysis
- Characterize the effect of dietary protein on ADPKD physiology and progression
- Discuss ADPKD research on ketogenic diets
- Describe the therapeutic role for targeting adiposity and caloric restriction in ADPKD
Learning Pathway(s)
- Genetic Diseases and Development
- CKD Non-Dialysis
Moderators
Presentations
- Biological Basis for Metabolic Treatment of ADPKD: Increased Aerobic Glycolysis (Warburg Effect)
04:30 PM - 04:50 PM
- Dietary Protein, Immune Cells, and ADPKD Progression
04:50 PM - 05:10 PM
- Ketogenic Diet and ADPKD
05:10 PM - 05:30 PM
- Targeting Adiposity and Caloric Restriction in ADPKD
05:30 PM - 05:50 PM
- Q&A
05:50 PM - 06:00 PM